Skip to main content

Find Clinical Trials

Home
Conditions
Hypersensitivity

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,763 public trials 649 recruiting studies

Refine in advanced search Browse all conditions

Hypersensitivity trial results

Completed

Leukocyte Function in Asthma and COPD

NCT00147069

Conditions: Asthma, Bronchial Diseases, Bronchitis, +18 more
Locations: Royal Brompton Hospital/NHLI Imperial College London London, United Kingdom

View Trial Details

Completed

Grass Pollen Allergen Immunotherapy Tablet (AIT) Time Course Study

NCT02005627

Conditions: Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +8 more
Locations: NHS Royal Brompton Hospital London, United Kingdom

View Trial Details

Completed

The Polymerase Chain Reaction (PCR) Analysis of Nasal Polyps for Fungal DNA

NCT00739921

Conditions: Allergic Fungal Sinusitis, Bacterial Infections and Mycoses, Hypersensitivity, +15 more
Locations: University of California, San Francisco, Dept of Otolaryngology-HNS San Francisco, California, United States

View Trial Details

Completed

Asthma and Obstructive Sleep Apnea (OSA)

NCT01026298

Conditions: Apnea, Asthma, Bronchial Diseases, +15 more
Locations: Univeristy of Wisconsin Hospital and Clinics Madison, Wisconsin, United States

View Trial Details

Completed

Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children

NCT02377427

Conditions: Asthma, Bronchial Diseases, Eosinophilia, +12 more
Locations: GSK Investigational Site San Diego, California, United States

GSK Investigational Site Oklahoma City, Oklahoma, United States

GSK Investigational Site Medford, Oregon, United States

GSK Investigational Site Madison, Wisconsin, United States

View all 16 locations

View Trial Details

Completed

Exacerbations in Severe Asthma Patients: Mechanisms and Biomarkers

NCT02660853

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Biomedical research Unit, Royal Brompton Hospital, Sydney Street London, United Kingdom

View Trial Details

Completed

A Study to Compare the Pharmacokinetics of Mepolizumab as a Liquid Drug in a Safety Syringe or an Autoinjector Versus Lyophilised Drug

NCT03014674

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Baltimore, Maryland, United States

GSK Investigational Site Berlin, Germany

GSK Investigational Site Harrow, Middlesex, United Kingdom

View Trial Details

Completed

A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects

NCT02135692

Conditions: Asthma, Bronchial Diseases, Eosinophilia, +12 more
Locations: GSK Investigational Site Newport Beach, California, United States

GSK Investigational Site Riverside, California, United States

GSK Investigational Site Rolling Hills Estates, California, United States

GSK Investigational Site Denver, Colorado, United States

View all 114 locations

View Trial Details

Completed

Clinical Endpoint Bioequivalence Study of Fluticasone Propionate & Salmeterol Xinafoate (100μg/50μg)

NCT03535870

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: West-Ward Research Site #1 Las Vegas, Nevada, United States

View Trial Details

Completed

Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic Participants

NCT02495168

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Site 100 Surprise, Arizona, United States

Site 101 Huntington Beach, California, United States

111 San Jose, California, United States

114 Centennial, Colorado, United States

View all 17 locations

View Trial Details